2021 annual financial data
Imunon 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -3,244.72%.
Operating income was -21,007,190 USD and net income was -20,769,250 USD.
Operating cash flow was -16,223,603 USD.
Get free Imunon email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 500,000 USD
- Operating income
- -21,007,190 USD
- Net income
- -20,769,250 USD
- Operating cash flow
- -16,223,603 USD